Cargando…
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios
As countries adopt more permissive cannabis policies, it is increasingly important to identify strategies that can reduce the harmful effects of cannabis use. This study aimed to determine if increasing the CBD content of cannabis can reduce its harmful effects. Forty-six healthy, infrequent cannabi...
Autores principales: | Englund, Amir, Oliver, Dominic, Chesney, Edward, Chester, Lucy, Wilson, Jack, Sovi, Simina, De Micheli, Andrea, Hodsoll, John, Fusar-Poli, Paolo, Strang, John, Murray, Robin M., Freeman, Tom P., McGuire, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156730/ https://www.ncbi.nlm.nih.gov/pubmed/36380220 http://dx.doi.org/10.1038/s41386-022-01478-z |
Ejemplares similares
-
Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022) -
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
por: Arkell, Thomas R., et al.
Publicado: (2019) -
Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
por: Pennypacker, Sarah D., et al.
Publicado: (2022) -
Assessing the adaptive role of cannabidiol (CBD) in Cannabis sativa defense against cannabis aphids
por: MacWilliams, Jacob, et al.
Publicado: (2023) -
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
por: Chesney, Edward, et al.
Publicado: (2021)